首页>投融资
ONWARD
上市后再融资
ONWARD Inc (previously known as GTX Medical) is a MedTech company focused on the development and commercialization of innovative therapies to accelerate and augment functional recovery of people with spinal cord injury and to improve their quality of life.In June 2022, ONWARD Inc received a grant from the European Commission of EUR 3.6 million to support the enhancement of an innovative brain-computer interface technology for restoring mobility and upper-limb function in people with spinal cord injury
基本信息
-
公司全称ONWARD Inc
-
类型植入式神经刺激器开发商
-
产业领域医疗器械
-
公司人数15~50人
-
地址High Tech Campus 32 EINDHOVEN NOORD-BRABANT 5656AE; NL;
-
联系电话
-
邮箱
-
成立时间2014-01-01
投融资
-
2024-10-24上市后再融资5400万美元未透露
-
2024-03-21上市后再融资2000万欧元未透露
-
2022-06-16上市后再融资120万欧元European Innovation Council
-
2021-10-21上市8700万欧元未透露
-
2021-04-22未透露3200万美元GimvInvest-NLINKEF CapitalOlympic InvestmentsWellington PartnersLife Sciences Partners
-
2019-03-19捐赠/众筹/授予未透露Eurostars
-
2016-04-19债权融资1000万欧元未透露
-
2016-04-19A轮2600万欧元Life Sciences PartnersGimvINKEF CapitalWellington Partners
-
2014-04-12捐赠/众筹/授予10万欧元未透露
- 加载更多
相关投融资企业
D轮
GT Medical Technologies Inc manufactures medical equipments.In March 2023, GT Medical Technologies Inc raised $45 million in a Series C financing
未公开
Alleviant Medical Inc.专注于开发一种微创医疗设备来治疗充血性心力衰竭。其专有的转式导管技术旨在通过缓解患者症状、提高生活质量和减少目前患有这种疾病的 600 多万美国人的住院时间，在治疗心力衰竭方面创造范式转变。
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息